poultry vaccine production
The Korean company, with over 50 years of experience and a portfolio of 85 veterinary vaccines, expressed interest in establishing a manufacturing plant in Egypt with an annual production capacity of 200 million doses. It also highlighted Egypt’s competitive advantages, including its expertise in producing pathogen-free fertilized eggs.
